<?xml version="1.0" encoding="UTF-8"?>
<abstract id="15705690">
  <title>
    <s id="0" section="title">
      <group id="0">
        Rectal
        <short>artemether</short>
      </group>
      versus
      <group id="1">
        intravenous
        <short>quinine</short>
      </group>
      for the treatment of cerebral malaria in children in Uganda : randomised clinical trial .
    </s>
  </title>
  <annotated>
    <s id="4" section="participants">
      <ps>103</ps>
      children aged 6 months to 5 years with cerebral malaria .
    </s>
    <s id="5" section="intervention">
      Patients were randomised to either
      <group id="1">
        intravenous
        <short>quinine</short>
      </group>
      or
      <group id="0">
        rectal
        <short>artemether</short>
      </group>
      for
      <time id="0">7  days</time>
      .
    </s>
    <s id="8" section="results">
      <outcome id="5" type="bad">Mortality</outcome>
      was higher in the
      <group id="1">quinine  group</group>
      than in the
      <group id="0">artemether  group</group>
      (
      <on group="1" outcome="5">10</on>
      /
      <gs group="1">52</gs>
      v
      <on group="0" outcome="5">6</on>
      /
      <gs group="0">51</gs>
      ; relative risk 1.29 , 95 % confidence interval 0.84 to 2.01 ) .
    </s>
  </annotated>
  <fulltext>Rectal artemether versus intravenous quinine for the treatment of cerebral malaria in children in Uganda : randomised clinical trial . To compare the efficacy and safety of rectal artemether with intravenous quinine in the treatment of cerebral malaria in children . Randomised , single blind , clinical trial . Acute care unit at Mulago Hospital , Uganda 's national referral and teaching hospital in Kampala . 103 children aged 6 months to 5 years with cerebral malaria . Patients were randomised to either intravenous quinine or rectal artemether for 7 days . Time to clearance of parasites and fever ; time to regaining consciousness , starting oral intake , and sitting unaided ; and adverse effects . The difference in parasitological and clinical outcomes between rectal artemether and intravenous quinine did not reach significance ( parasite clearance time 54.2 ( SD 33.6 ) hours v 55.0 ( SD 24.3 ) hours , P = 0.90 ; fever clearance time 33.2 ( SD 21.9 ) hours v 24.1 ( SD 18.9 hours , P = 0.08 ; time to regaining consciousness 30.1 ( SD 24.1 ) hours v 22.67 ( SD 18.5 ) hours , P = 0.10 ; time to starting oral intake 37.9 ( SD 27.0 ) hours v 30.3 ( SD 21.1 ) hours , P = 0.14 ) . Mortality was higher in the quinine group than in the artemether group ( 10 / 52 v 6 / 51 ; relative risk 1.29 , 95 % confidence interval 0.84 to 2.01 ) . No serious immediate adverse effects occurred . Rectal artemether is effective and well tolerated and could be used as treatment for cerebral malaria .</fulltext>
  <ignored>
    <s id="1" section="objective">
      To compare the efficacy and safety of
      <group id="0">
        rectal
        <short>artemether</short>
      </group>
      with
      <group id="1">
        intravenous
        <short>quinine</short>
      </group>
      in the treatment of cerebral malaria in children .
    </s>
    <s id="2" section="design">Randomised , single blind , clinical trial .</s>
    <s id="3" section="setting">Acute care unit at Mulago Hospital , Uganda 's national referral and teaching hospital in Kampala .</s>
    <s id="6" section="main_outcome_measures">
      <outcome id="0">Time  to  clearance  of  parasites  and  fever</outcome>
      ;
      <outcome id="1">time  to  regaining  consciousness</outcome>
      ,
      <outcome id="2">starting  oral  intake</outcome>
      , and
      <outcome id="3">sitting  unaided</outcome>
      ; and
      <outcome id="4">adverse  effects</outcome>
      .
    </s>
    <s id="7" section="results">
      The difference in parasitological and clinical outcomes between
      <group id="0">
        rectal
        <short>artemether</short>
      </group>
      and
      <group id="1">
        intravenous
        <short>quinine</short>
      </group>
      did not reach significance (
      <outcome id="0:0">parasite  clearance  time</outcome>
      54.2 ( SD 33.6 ) hours v 55.0 ( SD 24.3 ) hours , P = 0.90 ;
      <outcome id="0:1">fever  clearance  time</outcome>
      33.2 ( SD 21.9 ) hours v 24.1 ( SD 18.9 hours , P = 0.08 ;
      <outcome id="1">time  to  regaining  consciousness</outcome>
      30.1 ( SD 24.1 ) hours v 22.67 ( SD 18.5 ) hours , P = 0.10 ;
      <outcome id="2">time  to  starting  oral  intake</outcome>
      37.9 ( SD 27.0 ) hours v 30.3 ( SD 21.1 ) hours , P = 0.14 ) .
    </s>
    <s id="9" section="results">
      No serious immediate
      <outcome id="4">adverse  effects</outcome>
      occurred .
    </s>
    <s id="10" section="conclusion">
      <group id="0">
        Rectal
        <short>artemether</short>
      </group>
      is effective and well tolerated and could be used as treatment for cerebral malaria .
    </s>
  </ignored>
</abstract>

